Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

The CARI guidelines. Prevention of progression of kidney disease.

Harris D, Thomas M, Johnson D, Nicholls K, Gillin A; Caring for Australasians with Renal Impairment (CARI).

Nephrology (Carlton). 2006 Apr;11 Suppl 1:S2-197. No abstract available.

PMID:
16684077
2.

Clinical benefits of slowing the progression of renal failure.

Locatelli F, Del Vecchio L, Pozzoni P.

Kidney Int Suppl. 2005 Dec;(99):S152-6. Review.

PMID:
16336569
3.

Proteinuria as a therapeutic target in patients with chronic kidney disease.

Palmer BF.

Am J Nephrol. 2007;27(3):287-93. Epub 2007 Apr 23. Review.

4.

Modulating the progression in IgA nephropathy.

Chan JC, Trachtman H.

Nephron Clin Pract. 2006;104(1):c61-8. Epub 2006 Jun 1. Review.

5.

[Management of diabetic nephropathy with nephrotic syndrome].

Eguchi J, Wada J, Makino H.

Nihon Rinsho. 2002 Oct;60 Suppl 10:430-6. Review. Japanese. No abstract available.

PMID:
12430265
6.

Systemic hypertension and proteinuria in childhood chronic renal parenchymal disease: role of antihypertensive drug management.

Simonetti GD, Santoro L, Ferrarini A, Crosazzo-Franscini L, Fossali E, Bianchetti MG; CHILD Project.

Paediatr Drugs. 2007;9(6):413-8. Review.

PMID:
18052411
7.

[Basic principles of current trends in the management of hypertension and kidney disease in pregnancy].

Vajó Z, Székács B.

Orv Hetil. 1995 Nov 19;136(47):2561-6. Review. Hungarian.

PMID:
8532321
8.

Slowing chronic kidney disease progression: results of prospective clinical trials in adults.

Nguyen T, Toto RD.

Pediatr Nephrol. 2008 Sep;23(9):1409-22. doi: 10.1007/s00467-007-0737-2. Epub 2008 Mar 7. Review.

PMID:
18324425
9.

Protecting the kidney in hypertension.

Weinberg MS, Cottiero RA, Yoburn DC.

R I Med. 1993 May;76(5):225-8. Review. No abstract available.

PMID:
8518496
10.

[Etiology and therapy of kidney disease due to hypertension].

Ito S.

Nihon Naika Gakkai Zasshi. 1998 Jul 10;87(7):1292-7. Review. Japanese. No abstract available.

PMID:
9745278
11.

[Hypertension and renal dysfunction].

Yamanaka T, Okada M, Kimura G.

Nihon Rinsho. 2006 Aug;64 Suppl 6:196-200. Review. Japanese. No abstract available.

PMID:
16981542
12.

Antihypertensive therapy in the presence of proteinuria.

Sarafidis PA, Khosla N, Bakris GL.

Am J Kidney Dis. 2007 Jan;49(1):12-26. Review.

PMID:
17185142
13.

Evolving strategies for renoprotection: non-diabetic chronic renal disease.

Taal MW, Brenner BM.

Curr Opin Nephrol Hypertens. 2001 Jul;10(4):523-31. Review.

PMID:
11458034
14.

[Therapy of hypertension with kidney diseases].

Saruta T.

Nihon Naika Gakkai Zasshi. 1993 Apr 10;82(4):592-7. Review. Japanese. No abstract available.

PMID:
8340671
15.

Angiotensin converting enzyme inhibitors: the end of end-stage renal disease?

Feig PU, Rutan GH.

Ann Intern Med. 1989 Sep 15;111(6):451-3. Review. No abstract available.

PMID:
2672924
16.

Angiotensin receptor blockers: RAAS blockade and renoprotection.

Ruilope LM.

Curr Med Res Opin. 2008 May;24(5):1285-93. doi: 10.1185/030079908X291921 . Epub 2008 Mar 25. Review.

PMID:
18366863
17.

Immunoglobulin A nephropathy: fish oils and beyond.

Feehally J.

Curr Opin Nephrol Hypertens. 1996 Sep;5(5):442-6. Review.

PMID:
8937814
18.

[Strategies to slow the progression of chronic kidney disease].

Combe C, Rigothier C, Vendrely B, Chauveau P, Rigalleau V, Lasseur C.

Presse Med. 2007 Dec;36(12 Pt 2):1849-55. Epub 2007 Jul 25. Review. French.

PMID:
17656065
19.

[Inhibition of the progression of renal failure in glomerular diseases].

Ritz E, Siebels M, Fliser D.

Internist (Berl). 1993 Apr;34(4):330-9. Review. German. No abstract available.

PMID:
8486477
20.

Non-antiarrhythmic drugs in atrial fibrillation: a review of non-antiarrhythmic agents in prevention of atrial fibrillation.

Lally JA, Gnall EM, Seltzer J, Kowey PR.

J Cardiovasc Electrophysiol. 2007 Nov;18(11):1222-8. Epub 2007 Jun 6. Review.

PMID:
17553070
Items per page

Supplemental Content

Write to the Help Desk